Vestal Point Capital »

Tenax Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $288k 83k 3.46

More positions owned by Vestal Point Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Inari Medical Ord (NARI)
Arcellx Common Stock (ACLX)
Structure Therapeutics Sponsored Ads (GPCR)
Kalvista Pharmaceuticals (KALV)
Astria Therapeutics (ATXS)
Immatics NV SHS (IMTX)
Ultragenyx Pharmaceutical (RARE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Day One Biopharmaceuticals I (DAWN)
Savara (SVRA)
Agios Pharmaceuticals (AGIO)

View all positions for Vestal Point Capital

Top funds holding Tenax Therapeutics

BVF
VR Adviser
Vestal Point Capital
Stonepine Capital Management
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Lynx1 Capital Management
Qube Research & Technologies
Tower Research Capital
BlackRock
BlackRock
Morgan Stanley
Bank of America Corporation
Hanson McClain Advisors

View all funds holding Tenax Therapeutics